Investors can't help gorging on anti-obesity drugs

Roche is belatedly buying its way into the booming market for weight-loss treatments, with a $3 billion biotech deal

Related Keywords

Denmark ,Switzerland ,California ,United States ,China ,Swiss ,Danish ,Chinese ,Thomas Schinecker ,Eccogene Inc ,Eli Lilly Co ,Roche Holding ,Astrazeneca ,Barclays Plc ,Morgan Stanley ,Bloomberg Intelligence ,Indianapolis Based Eli Lilly ,Chief Executive Officer Thomas Schinecker ,Carmot Therapeutics ,Investor ,Pharmaceuticals ,Drugs ,Bloomberg ,Anti Obesity Drugs ,